In this episode, we unpack what APOE actually does, why it matters for moving cholesterol and other lipids, and why that becomes especially important in the brain. We also cover the three common APOE versions, what amyloid is, why APOE4 gets so much attention in Alzheimer’s research, and why genetic risk should never be confused with destiny.

We also explore the difference between APOE and the rarer genes tied to inherited early onset Alzheimer’s disease, why APOE4 homozygosity has drawn more attention in recent research, and how this gene now shows up in some treatment decisions involving anti amyloid therapies and ARIA risk.

APOE is not just a fear gene. It is part of a larger system involving transport, repair, and long term brain biology. And once you understand that, the conversation shifts. It stops being about panic, and it starts becoming about interpretation, context, and what you do with the terrain you’ve been given.

Your biology listens. Live like it.

Timestamps

0:00 Intro

0:52 What APOE actually is

1:56 Why lipid transport matters in the brain

3:18 The three common APOE versions

4:36 Why risk does not mean destiny

5:48 Amyloid, brain aging, and why APOE gets attention

7:18 Risk genes versus rare causative genes

8:34 The 2024 APOE4 homozygosity shift

9:42 Why ancestry and context matter

10:28 APOE and treatment risk with ARIA

11:28 What to do with this information in real life

12:18 Closing perspective

Key Terms

APOE: Apolipoprotein E. A gene involved in packaging and transporting cholesterol and other lipids.

Lipid: A fat or fat-like molecule used for structure, signaling, energy storage, and repair.

Allele: A version of a gene.

Amyloid: Protein fragments, especially amyloid beta, that can collect into plaques in the brain and are associated with Alzheimer’s disease.

APOE4 homozygosity: Inheriting two APOE4 copies, one from each biological parent.

ARIA: Amyloid-related imaging abnormalities. Changes seen on brain imaging during treatment, often swelling or small areas of bleeding.

Risk gene: A gene that changes likelihood rather than guaranteeing an outcome.

References

National Institute on Aging. Alzheimer’s Disease Genetics Fact Sheet.

MedlinePlus Genetics. APOE gene.

Mayo Clinic. Alzheimer’s genes: Are you at risk?

Fortea J, et al. APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease. Nature Medicine, 2024.

National Institute on Aging. Study defines major genetic form of Alzheimer’s disease.

FDA prescribing information for LEQEMBI.

FDA prescribing information for KISUNLA.

Disclaimer

*The Unlocked Podcast is educational content, not medical advice. For personal medical decisions, consult a qualified professional.

Episode Notes

Most people have never heard of FTO, but once you understand what it is, a lot of the body weight conversation starts making more sense. This episode breaks down how researchers first found FTO, why it became such an important part of obesity genetics, what the early numbers actually showed, why the first diabetes signal changed once body mass index was factored in, how this gene region may connect to appetite and food cues, where GLP 1 overlaps with that biology, and what training, movement, sleep, stress, and food quality can still change in real life.

Timestamps

0:00 Opening

0:53 What FTO actually is

1:48 How researchers first found it

2:40 What GWAS means

3:24 What BMI means

4:13 Why the early diabetes signal changed

5:18 What FTO may be influencing in the body

6:32 Appetite, hunger, and food cue biology

8:00 Ghrelin and why hunger may feel louder

9:19 Fat cell programming, IRX3, and IRX5

10:42 Where GLP 1 overlaps with the conversation

11:58 Why FTO does not cleanly predict GLP 1 response

12:43 What lifestyle can still change

13:22 Physical activity and the FTO risk signal

14:14 Weight training, sleep, stress, and food structure

15:22 Practical takeaways

16:02 Closing

Key Terms

FTO

Fat mass and obesity associated gene. A gene region strongly associated with body weight risk in common genetics research.

GWAS

Genome wide association study. A method used to scan the genome for common variants linked to traits or disease across large populations.

BMI

Body mass index. A rough height to weight measure often used in large population studies.

rs9939609

One of the most studied FTO variants in obesity research. In many studies, the A allele is associated with higher average body weight risk.

Ghrelin

A hormone involved in hunger signaling and appetite regulation.

GLP 1

Glucagon like peptide 1. A hormone involved in satiety, appetite regulation, and gastric emptying. GLP 1 receptor agonists act on that pathway.

IRX3 and IRX5

Genes implicated in mechanistic studies of how obesity associated variation in the FTO region may influence fat cell programming.

References

Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316(5826):889 to 894.

Scuteri A, Sanna S, Chen WM, et al. Genome wide association scan shows genetic variants in the FTO gene are associated with obesity related traits. PLoS Genetics. 2007;3(7):e115.

Karra E, O’Daly OG, Choudhury AI, et al. A link between FTO, ghrelin, and impaired brain food cue responsivity. Journal of Clinical Investigation. 2013;123(8):3539 to 3551.

Kilpeläinen TO, Qi L, Brage S, et al. Physical activity attenuates the influence of FTO variants on obesity risk: a meta analysis of 218,166 adults and 19,268 children. PLoS Medicine. 2011;8(11):e1001116.

Claussnitzer M, Dankel SN, Kim KH, et al. FTO obesity variant circuitry and adipocyte browning in humans. New England Journal of Medicine. 2015;373(10):895 to 907.

Zheng Z, et al. Glucagon like peptide 1 receptor: mechanisms and advances. Frontiers in Endocrinology. 2024.

German J, et al. Association between plausible genetic factors and weight loss from GLP1 RA and bariatric surgery. Nature Medicine. 2025;31(7):2269 to 2276.

Disclaimer

*The Unlocked Podcast is educational content, not medical advice. For personal medical decisions, consult a qualified professional.

Episode Notes

This episode breaks down synergistic supplements and antagonistic supplements with a baseline first, food first approach. The goal is to stop guessing, stop stacking everything at once, and start using a simple framework that helps you understand what pairs well, what competes, and how to change one variable at a time so your body gives readable feedback.

You’ll also hear a short medical history thread about healing, fear, and why mechanism matters, because understanding the body is how results become repeatable instead of feeling like luck.

Timestamps

00:00 Why stacks feel random

02:00 Synergistic and antagonistic, simple definitions

03:15 Blood work first, groups of labs, vitamin D test

05:46 Food first and when supplements make sense

08:01 The mechanism logic behind synergy and antagonism

10:16 The history thread, including trials, executions, and why healers were targeted

12:31 Iron and vitamin C, calcium timing

15:47 Fat soluble vitamins with meals

17:32 Zinc and copper, when it becomes a problem

19:17 St. John’s wort safety category

20:32 Wrap up and what’s next

What’s Next

Episode 9 - focused on FTO.

Key Terms

Synergistic: two inputs work better together

Antagonistic: two inputs compete and reduce effect

CBC: complete blood count

CMP: comprehensive metabolic panel

25 hydroxy vitamin D: main blood test for vitamin D status

Methylmalonic acid: marker often used for B12 deficiency evaluation

Homocysteine: marker related to methylation and B vitamin status

Serum retinol: vitamin A blood marker

Alpha tocopherol: vitamin E blood marker

Phylloquinone: vitamin K1 marker

Keywords

Supplement synergy

Supplement antagonism

Blood work baseline

CBC CMP

Iron vitamin C

Calcium iron separation

Fat soluble vitamins

Zinc copper balance

St. John’s wort interactions

One variable testing

FTO

References

NIH Office of Dietary Supplements fact sheets on iron, vitamin C, vitamin D, zinc, copper, B12, folate

MedlinePlus lab test explanations for CBC, CMP, vitamin D test, ferritin, methylmalonic acid, homocysteine

Clinical pharmacology reviews on St. John’s wort interactions with medications

Your biology listens. Live like it.

MTHFR is a real gene in the folate pathway, but it often gets treated like it explains everything. This episode keeps the scale right. You’ll learn what the enzyme does, why homocysteine became a popular lab marker, and how to separate association evidence from intervention evidence so you don’t get misled by a number moving without outcomes changing. You’ll also get a simple decision model you can use without spiraling.

You’ll learn:

• What MTHFR actually does inside folate metabolism

• Why folate was historically studied in medicine

• How homocysteine became a biomarker

• Why association studies and randomized trials tell different stories

• What DNA methylation actually means

• Why this is a pathway discussion, not a personality explanation

This episode separates evidence types carefully and keeps claims proportional to data.

Timestamps

0:00 Primary intro

1:05 Why MTHFR gets inflated in conversation

2:00 Folate history and why it mattered in medicine

3:00 One carbon metabolism explained clearly

4:15 What MTHFR enzyme actually does

5:20 B12 as cofactor and why this is a pathway, not a solo gene

6:10 Homocysteine as a biomarker and what association means

7:20 Randomized trials lowering homocysteine and outcome nuance

8:40 DNA methylation defined properly

9:50 What MTHFR does not control

10:40 Mendelian randomization and causality

11:30 Micro protocol and bridge to Part 2

Key Terms

Folate: A B vitamin required for DNA synthesis and red blood cell formation. Named from the Latin “folium,” meaning leaf.

One carbon metabolism: A network of reactions that transfer single carbon units for DNA synthesis and methylation reactions.

MTHFR: Methylenetetrahydrofolate reductase, an enzyme that converts one form of folate into another needed for homocysteine recycling.

Enzyme: A protein that speeds up a chemical reaction.

Homocysteine: An intermediate amino acid in methionine metabolism that can accumulate if recycling is impaired.

Methionine: An essential amino acid involved in protein synthesis and methyl group donation.

Vitamin B12: A vitamin that acts as a cofactor for methionine synthase in homocysteine conversion.

Cofactor: A helper molecule required for an enzyme to function.

Biomarker: A measurable biological indicator, often assessed through blood testing.

Association: When two variables move together statistically; does not prove cause.

Randomized controlled trial: A study design that assigns participants by chance to test cause and effect.

DNA methylation: The addition of methyl groups to DNA that can influence gene expression levels.

Gene expression: The process by which a gene is used to produce a protein.

Mendelian randomization: A genetics based method using variants as natural experiments to estimate causality.

Keywords

MTHFR, folate cycle, homocysteine, methylation, one carbon metabolism, B12, C677T, gene expression, cardiovascular risk, Mendelian randomization

References

NIH Office of Dietary Supplements. Folate Fact Sheet for Health Professionals.

NIH Office of Dietary Supplements. Vitamin B12 Fact Sheet for Health Professionals.

HOPE 2 Investigators. NEJM. 2006.

NORVIT Trial Investigators. NEJM. 2006.

Clarke R et al. Homocysteine and vascular disease. JAMA. 2002.

Recent Mendelian randomization analyses on homocysteine and cardiovascular outcomes, 2018–2023.

A short guided practice to downshift, recover, and ground the nervous system.

This episode is a guided nervous system reset designed to help you downshift from stress, stimulation, or mental overload.

You don’t need a yoga studio, special equipment, or prior experience. This practice can be done seated or lying down, at home, after work, after training, or before sleep.

The breathing and awareness used here are intended to support recovery by gently shifting the nervous system out of a high-alert state and toward a calmer, more regulated one. Over time, practices like this can support better sleep, digestion, emotional regulation, and overall recovery.

This session is not about forcing relaxation or clearing the mind. It’s about giving the body enough space to settle naturally.

You can return to this reset anytime you feel overstimulated, scattered, or in need of grounding.

What You Need

A quiet space where you can sit or lie down comfortably.

A chair, mat, couch, or bed all work.

Optional: a light blanket if the room is cool.

After the Practice

Try to keep the transition gentle.

Hydration is helpful.

If you eat afterward, warm, grounding foods are often more settling than highly stimulating options.

Your biology listens. Live like it.

Episode 5 is a short, high-energy activation episode focused on momentum rather than discipline. Instead of relying on motivation as a prerequisite, this episode explains how movement itself acts as a biological signal that organizes focus, clarity, and drive. The emphasis is on reducing friction, using small actions to shift nervous system state, and creating traction without pressure. This episode is designed to be listened to in real time, especially before work, training, or any task that requires initiation.

Energy Adjustment Options

High-performance days:

Read at a slightly faster pace, with clearer posture cues and more vocal lift in the middle section.

Lower-energy or burnout days:

Slow the pacing slightly, soften the emphasis, and allow longer pauses between sentences to reduce pressure.

Your biology listens. Live like it.

Episode 4 explores ACTN3, a gene tied to fast-twitch muscle fiber structure, and how muscle architecture influences strength, speed, fatigue, and recovery. We move beyond genetic labels and focus on how structure, energy systems, and training signals interact to shape performance over time.

The episode traces the scientific history of ACTN3, beginning with the identification of the R577X variant and early athlete association studies, then moves into mechanistic research using Actn3 knockout models to explain why some bodies respond differently to power and endurance demands.

Rather than treating genetics as destiny, this episode frames ACTN3 as a structural context that influences training cost, energy use, and recovery timelines. We connect muscle architecture to ATP demand, nervous system load, and how training converts into adaptation rather than lingering fatigue.

The practical section introduces a simple one-week “conversion” experiment to help listeners observe how their own system responds to strength-biased versus volume-biased training, without needing a genetic test.

This episode sets the foundation for future discussions on training precision, recovery architecture, and the long-term direction of performance systems, regeneration, and bio-integrated technology.

Timestamps

(0:00 Introduction and framing ACTN3 as structure, not identity

1:10 Muscle architecture overview and why fiber structure matters

2:20 ACTN3 history and the R577X variant

3:35 Athlete association studies and population-level findings

4:55 Mechanistic research and Actn3 knockout models

6:30 Muscle metabolism, ATP demand, and training cost

8:05 Conversion versus fatigue and why recovery timelines differ

9:40 One-week conversion experiment explained

11:30 How this fits into long-term performance systems

13:05 Episode summary and close

Key Terms

ACTN3: A gene that codes for alpha-actinin-3, a structural protein found in fast-twitch muscle fibers.

Alpha-actinin-3: A protein involved in anchoring actin filaments in fast-twitch muscle fibers.

Fast-twitch fibers: Muscle fibers specialized for high-force, high-speed output.

ATP (Adenosine Triphosphate): The primary energy currency used by cells to perform work.

Aerobic metabolism: Energy production that relies more heavily on oxygen-supported pathways.

Conversion: How effectively training effort translates into repeatable adaptation rather than fatigue.

Muscle architecture: The structural arrangement of muscle fibers and contractile elements.

Your biology listens. Live like it.

References

North KN et al. (1999). A common nonsense mutation results in alpha-actinin-3 deficiency in the general population.

Yang N et al. (2003). ACTN3 genotype is associated with human elite athletic performance.

MacArthur DG et al. (2007). Loss of ACTN3 gene function alters muscle metabolism and performance in mice.

MacArthur DG et al. (2008). Structural and metabolic consequences of ACTN3 deficiency.

RSS Footer Disclaimer

The Unlocked Podcast is educational content, not medical advice. For personal medical decisions, consult a qualified professional.

Episode 3 uses COMT as a practical lens for understanding signal duration and clearance in focus and stress physiology. We trace COMT through the mid 20th century discovery era of neurotransmitter inactivation, then connect it to prefrontal cortex function and later human genetics work on functional variation such as Val158Met. The episode stays focused on real world patterns like wired but tired and fog, then gives repeatable experiments around caffeine timing, light timing, sleep stability, training structure, and downshift rituals. The aim is a cleaner signal, steadier attention, and more predictable recovery, especially for high demand lifestyles like students building a business. Key Terms functions as the glossary, and listening again after vocabulary is familiar typically makes the episode land differently.

Timestamps

0:00 Story opener and the real world focus problem

2:35 Bridge into COMT and what clearance means in plain language

4:05 COMT, catecholamines, and signal duration

5:30 Prefrontal cortex, attention control, and performance under stress

6:45 Here’s a little context from the research history, why COMT entered the science story

9:30 Demand and clearance as the practical model

10:45 Wired but tired and fog patterns, how modern life amplifies both 12:20 Repeatable levers, timing, sleep stability, training structure, downshift

14:10 Cybernetics bridge, biology as feedback loops

15:25 Reminder pass, Key Terms glossary cue,

Key Terms

COMT: Catechol O methyltransferase, an enzyme involved in metabolizing catecholamines through methylation related chemistry.

Catecholamines: Neurochemicals involved in alertness, motivation, and stress response, including dopamine, norepinephrine, and epinephrine.

Dopamine: A neurotransmitter involved in motivation, attention, learning, and reward signaling.

Norepinephrine: A neurotransmitter and hormone involved in alertness, arousal, and stress response.

Epinephrine: Also called adrenaline, involved in acute stress response and energy mobilization.

Prefrontal cortex: Brain region involved in planning, working memory, attention control, impulse control, and decision making.

Gene expression: Which genetic instructions are used more or less often under certain conditions, without changing the DNA sequence.

Clearance: How the body breaks down and removes chemical signals over time, shaping how long a stress or focus state stays active.

Signal noise: Excess stimulation and stress input that makes focus, mood, and recovery less stable.

Feedback loop: A system where outputs influence future inputs, central to cybernetics and biological regulation.

Physiology: How the body functions in real time, including nervous system activity, hormones, metabolism, and recovery processes.

Adaptation: A lasting change after repeated signals, where the body becomes better at handling the same demand.

References

MedlinePlus Genetics. COMT gene overview.

Tunbridge EM, Harrison PJ, Weinberger DR. Catechol O methyltransferase, cognition, and dopamine regulation in prefrontal cortex. Review.

McEwen BS. Stress, adaptation, and allostatic load framework.

Goldman Rakic PS. Prefrontal cortex and executive function foundational work.

Axelrod J. Early foundational work on O methylation of catecholamines.